Bioinformatics Market

Bioinformatics Market Size, Market Forecast and Outlook By FMI

Summary of the Bioinformatics Market

• Demand and Growth Drivers
  • Rapid expansion of genomic data generation through next generation sequencing is creating sustained demand for computational analysis platforms and data management tools.
  • Pharmaceutical and biotech investment in precision medicine, drug target identification, and clinical genomics is supporting platform adoption and service procurement.
  • Integration of AI and machine learning capabilities into bioinformatics workflows is expanding the analytical scope and commercial value of available platforms and services.
• Product and Segment View
  • Bioinformatics Platforms is expected to hold 37.4% of the product segment in 2026, reflecting established demand and procurement preference across end use categories.
  • Genomics is expected to account for 32.9% of the application segment, supported by consistent application requirements and volume demand.
  • The sector segment includes Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, with adoption patterns varying by geography and buyer profile.
• Geography and Competitive Outlook
  • India is expected to lead growth at 11.8%, supported by scale of domestic production, infrastructure investment, and expanding end use demand.
  • China is projected to grow at 11.2%, reflecting regulatory support and ongoing procurement modernization across key application areas.
  • Thermo Fisher Scientific Inc. and other established participants are expected to maintain competitive positioning through manufacturing scale, distribution networks, and product portfolio breadth.
• Analyst Opinion
  • The bioinformatics market is transitioning from a research support function into a core infrastructure requirement for pharmaceutical development, clinical genomics, and agricultural biotechnology.
  • Bioinformatics platforms lead product demand due to their role in managing and analyzing large scale sequencing datasets, with cloud based deployment expanding accessibility across institutional users.
  • Growth reflects the intersection of declining sequencing costs and expanding data complexity, which together are increasing reliance on computational biology tools.
  • Participants with integrated workflows spanning sample preparation, data analysis, and interpretation reporting are positioned to capture institutional procurement contracts.

Key Takeaways

• The bioinformatics market was valued at USD 18.70 billion in 2025.
• By 2036, the Bioinformatics Market is expected to be worth USD 65.05 billion.
• From 2026 to 2036, the market is projected to expand at a CAGR of 12%.
• The market is projected to create an incremental opportunity of USD 44.11 billion between 2026 and 2036.
• In 2026, Bioinformatics Platforms is expected to account for 37.4% of the product segment, driven by integration with next generation sequencing workflows and demand from pharmaceutical and academic research institutions.
• India (11.8%) and China (11.2%) are two of the fastest growing markets in the world.

Bioinformatics Market Definition

The bioinformatics market encompasses software platforms, analytical services, knowledge management tools, and biocontent databases used for the computational analysis of biological data. Applications span genomics, molecular phylogenetics, metabolomics, proteomics, transcriptomics, and chemoinformatics across medical, animal, plant, environmental, and forensic biotechnology sectors.

Bioinformatics Market Inclusions

Market scope encompasses all commercially traded products categorized by product (Bioinformatics Platforms, Bioinformatics Services, Knowledge Management Tools, Biocontent); application (Genomics, Molecular Phylogenetics, Metabolomics, Proteomics, Transcriptions, Chemoinformatics and Drug Designing); sector (Medical Biotechnology, Animal Biotechnology, Plant Biotechnology, Environmental Biotechnology, Forensic Biotechnology); offering (Software, Services). Revenue coverage spans from 2026 to 2036 across North America, Latin America, Europe, East Asia, South Asia and Pacific, and Middle East and Africa.

Bioinformatics Market Exclusions

The scope does not include general purpose IT infrastructure, electronic health record (EHR) systems, or laboratory information management systems (LIMS) that do not incorporate bioinformatics analytical capabilities. Raw sequencing instruments and wet lab reagents are also excluded.

Bioinformatics Market Research Methodology

• Primary Research: FMI analysts conducted interviews with industry participants, product specialists, and distribution channel stakeholders across key geographies.
• Desk Research: Aggregated data from trade associations, regulatory filings, and manufacturer disclosures to build a comprehensive market baseline.
• Market Sizing and Forecasting: Applied a bottom up methodology across product segments, end use categories, and regional adoption curves to arrive at market valuations from 2026 to 2036.
• Data Validation: Cross verified quarterly against production data, trade statistics, and manufacturer reported figures to maintain forecast accuracy.

Why is the Bioinformatics Market Growing?

• Declining sequencing costs and increasing data volumes from genomics, proteomics, and transcriptomics research are driving demand for computational analysis platforms and services.
• Pharmaceutical investment in AI powered drug discovery and precision medicine is expanding the commercial application of bioinformatics tools beyond academic research.
• India leads growth at 11.8%, supported by expanding biotech R&D capacity and government investment in genomics initiatives.

The bioinformatics market is undergoing rapid expansion as the volume and complexity of biological data increase across research, clinical, and commercial applications. Bioinformatics platforms hold 37.4% of the product segment, reflecting their central role in managing sequencing data, performing alignment and variant calling, and supporting multi omics analysis workflows.

Genomics accounts for 32.9% of the application segment, driven by the expansion of whole genome sequencing, clinical exome analysis, and population genomics studies. Molecular phylogenetics, metabolomics, proteomics, and chemoinformatics represent additional high growth application areas as researchers seek integrated computational approaches to complex biological questions.

Medical biotechnology leads the sector segment, supported by pharmaceutical R&D investment in drug target identification, biomarker discovery, and companion diagnostics. India (11.8%) and China (11.2%) are the fastest growing markets, driven by government genomics programs, expanding biotech R&D capacity, and increasing academic research output in computational biology.

Market Segmentation Analysis

• Bioinformatics Platforms holds 37.4% of the product segment, reflecting established demand and procurement patterns across key end use categories.
• Genomics accounts for 32.9% of the application segment, supported by volume consumption and established application requirements.
• Offering channels include Software, Services, with institutional procurement representing the primary demand pathway.

The bioinformatics market is segmented by product, application, sector, offering. Each segment reflects distinct demand drivers, buyer profiles, and competitive dynamics.

Insights into the Bioinformatics Platforms Product Segment

Bioinformatics platforms hold 37.4% of the product segment in 2026, reflecting their central role in sequencing data management, variant analysis, and multi omics workflow integration. Cloud based platform deployment is expanding accessibility for smaller research institutions and clinical laboratories. Bioinformatics services represent a growing complement, with contract analysis providers serving pharmaceutical companies and academic groups that lack in house computational capacity.

Insights into the Genomics Application Segment

Genomics accounts for 32.9% of the application segment, driven by whole genome sequencing adoption, clinical exome analysis, and population scale genomics initiatives. The declining cost of sequencing is increasing data generation rates, which in turn sustains demand for bioinformatics tools that can manage, analyze, and interpret large datasets. Molecular phylogenetics and chemoinformatics applications are expanding as researchers apply computational methods to evolutionary biology and drug discovery.

Bioinformatics Market Drivers, Restraints, and Opportunities

• Declining sequencing costs and expanding genomic data volumes are increasing institutional demand for computational analysis platforms, cloud infrastructure, and bioinformatics services.
• Data security, interoperability challenges, and the need for specialized computational expertise limit adoption among smaller research institutions and clinical laboratories.
• AI powered analytics and machine learning integration are expanding the commercial scope of bioinformatics tools into pharmaceutical development, precision medicine, and agricultural biotechnology.

The bioinformatics market continues to evolve as structural demand shifts, regulatory requirements, and competitive dynamics influence adoption patterns across segments and geographies. Growth is supported by expanding end use demand, while constraints related to cost, compliance, and supply chain complexity create differentiated adoption rates across buyer categories.

Genomic Data Volume Expansion

Declining sequencing costs are driving exponential growth in genomic data generation, creating sustained demand for bioinformatics platforms capable of managing, analyzing, and storing large datasets. Cloud computing infrastructure is enabling scalable data processing for institutional users.

AI and Machine Learning Integration

AI powered analytics are expanding the functional scope of bioinformatics tools, enabling pattern recognition, predictive modeling, and automated variant interpretation that accelerate research and clinical decision making.

Data Security and Interoperability Constraints

Concerns about patient data privacy, cross platform interoperability, and regulatory compliance with data handling requirements create adoption friction, particularly for clinical bioinformatics applications subject to healthcare data regulations.

Pharmaceutical R&D Investment

Drug discovery programs increasingly rely on bioinformatics for target identification, biomarker development, and clinical trial design. Pharmaceutical investment in computational biology is expanding the commercial application of bioinformatics tools beyond academic research settings.

Analysis of Bioinformatics Market By Key Countries

Country	CAGR
India	11.8%
China	11.2%
South Korea	10.4%
USA	9.6%
UK	9.1%

• India leads with 11.8% CAGR, supported by domestic market scale, infrastructure investment, and expanding end use demand across key application categories.
• China at 11.2% reflects sustained demand driven by regulatory support, procurement modernization, and established institutional buyer networks.
• South Korea (10.4%) and USA (9.6%) demonstrate ongoing growth through regulatory compliance driven adoption and expanding end use applications.

The global bioinformatics market is expected to grow at a rate of 12% per year from 2026 to 2036. The study covers more than 30 countries, and the main markets are listed below.

Demand Outlook for Bioinformatics Market in India

India is projected to grow at 11.8% through 2036, driven by government investment in genomics research programs, expanding biotech R&D capacity, and a growing pool of computational biology talent across academic and commercial institutions.

• Government genomics research programs drive institutional platform procurement.
• Growing biotech R&D sector supports demand for analytical services and software.
• Expanding computational biology talent pool reduces adoption barriers for research institutions.

Future Outlook for Bioinformatics Market in China

China is expected to grow at 11.2% through 2036, supported by large scale national genomics initiatives, pharmaceutical R&D expansion, and increasing adoption of AI powered bioinformatics platforms in clinical and agricultural applications.

• National genomics initiatives create large scale demand for bioinformatics infrastructure.
• AI powered platform adoption is expanding across pharmaceutical and agricultural applications.
• Domestic bioinformatics companies are gaining market presence alongside global platform providers.

Opportunity Analysis of Bioinformatics Market in South Korea

South Korea is projected to grow at 10.4% through 2036, reflecting strong government support for precision medicine, advanced IT infrastructure enabling cloud based bioinformatics deployment, and active pharmaceutical R&D investment.

• Government precision medicine initiatives drive institutional bioinformatics adoption.
• Advanced IT infrastructure supports cloud based platform deployment and data management.
• Active pharmaceutical R&D investment sustains demand for computational analysis tools.

In-depth Analysis of Bioinformatics Market in USA

The USA is expected to grow at 9.6% through 2036, driven by pharmaceutical R&D investment, NIH funded genomics research, and institutional procurement of bioinformatics platforms by academic medical centers and clinical laboratories.

• Pharmaceutical R&D investment and NIH funded genomics research sustain platform demand.
• Academic medical centers represent major institutional buyers of bioinformatics platforms.
• Clinical genomics adoption in hospital settings is expanding the commercial application base.

Sales Analysis of Bioinformatics Market in UK

The UK is projected to grow at 9.1% through 2036, supported by the Genomics England program, strong academic research output, and pharmaceutical industry adoption of computational biology tools for drug discovery and development.

• Genomics England program drives institutional procurement of bioinformatics platforms and services.
• Strong academic research output supports demand for computational biology tools.
• Pharmaceutical industry adoption of bioinformatics accelerates drug discovery workflows.

Competitive Landscape and Strategic Positioning

• Thermo Fisher Scientific Inc. maintains a leading position through manufacturing scale, product breadth, and established distribution relationships across key geographies.
• Eurofins Scientific and QIAGEN N.V. compete on product specialization, regional market access, and application specific capabilities.
• Emerging participants are targeting niche segments and specialized applications where product differentiation and technical expertise create competitive positioning opportunities.

Thermo Fisher Scientific Inc. holds a leading competitive position supported by manufacturing infrastructure, distribution network reach, and product portfolio breadth across multiple segments. Eurofins Scientific competes on product range and geographic coverage.

Mid tier participants including QIAGEN N.V., Agilent Technologies Inc., Illumina Inc. maintain competitive positioning through regional market access, application expertise, and customer relationship depth in specific end use categories.

Market entry barriers include established supply chain relationships, regulatory approval requirements, production scale economics, and the need for technical application support. Companies competing in this market must balance cost competitiveness with product quality and compliance requirements to sustain procurement relationships.

Key Companies in the Bioinformatics Market

Key global companies leading the bioinformatics market include:

• Thermo Fisher Scientific Inc., Eurofins Scientific, QIAGEN N.V., Agilent Technologies Inc. hold established positions through manufacturing scale, distribution reach, and product breadth across multiple segments and geographies.
• Illumina Inc., Waters Corporation, NeoGenomics Laboratories have built regional strength through focused product portfolios and proximity to key end use markets.
• PerkinElmer Inc., Fios Genomics, Source BioScience represent emerging participants investing in specialized product development and niche applications to expand market presence.

Competitive Benchmarking: Bioinformatics Market

Company	Platform Capability	Application Coverage	Customer Base	Geographic Reach
Thermo Fisher Scientific Inc.	High	High	Strong	Global
Eurofins Scientific	High	High	Strong	Global
QIAGEN N.V.	Medium	High	Moderate	Regional
Agilent Technologies Inc.	Medium	Medium	Moderate	Regional
Illumina Inc.	Medium	Medium	Moderate	Regional
Waters Corporation	Low	Medium	Moderate	Regional
NeoGenomics Laboratories	Low	Low	Low	Niche
PerkinElmer Inc.	Low	Low	Low	Niche
Fios Genomics	Low	Low	Low	Niche
Source BioScience	Low	Low	Low	Niche

Source: Future Market Insights competitive analysis, 2026.

Key Players in the Bioinformatics Market

Major Global Players

• Thermo Fisher Scientific Inc.
• Eurofins Scientific
• QIAGEN N.V.
• Agilent Technologies Inc.
• Illumina Inc.
• Waters Corporation
• NeoGenomics Laboratories

Emerging Players/Startups

• PerkinElmer Inc.
• Fios Genomics
• Source BioScience

Report Scope and Coverage

Parameter	Details
Quantitative Units	USD 20.94 billion to USD 65.05 billion, at a CAGR of 12%
Market Definition	The bioinformatics market covers computational platforms, services, and tools for analyzing biological data across research and clinical applications.
Regions Covered	North America, Latin America, Europe, East Asia, South Asia and Pacific, Middle East and Africa
Countries Covered	India, China, South Korea, USA, UK, 30 plus countries
Key Companies Profiled	Thermo Fisher Scientific Inc., Eurofins Scientific, QIAGEN N.V., Agilent Technologies Inc., Illumina Inc., Waters Corporation, NeoGenomics Laboratories, PerkinElmer Inc., Fios Genomics, Source BioScience
Forecast Period	2026 to 2036
Approach	Hybrid bottom up and top down methodology starting with verified transaction data, projecting adoption velocity across segments and regions.

Segmentation

Bioinformatics Market Segmented by Product:

• Bioinformatics Platforms
• Bioinformatics Services
• Knowledge Management Tools
• Biocontent

Bioinformatics Market Segmented by Application:

• Genomics
• Molecular Phylogenetics
• Metabolomics, Proteomics
• Transcriptions
• Chemoinformatics and Drug Designing

Bioinformatics Market Segmented by Sector:

• Medical Biotechnology
• Animal Biotechnology
• Plant Biotechnology
• Environmental Biotechnology
• Forensic Biotechnology

Bioinformatics Market Segmented by Offering:

• Software
• Services

Bioinformatics Market by Region:

• North America
  • USA
  • Canada
  • Mexico
• Latin America
  • Brazil
  • Chile
  • Rest of Latin America
• Western Europe
  • Germany
  • UK
  • Italy
  • Spain
  • France
  • Nordic
  • BENELUX
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltic
  • Rest of Eastern Europe
• East Asia
  • China
  • Japan
  • South Korea
• South Asia and Pacific
  • India
  • ASEAN
  • Australia & New Zealand
  • Rest of South Asia and Pacific
• Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkiye
  • South Africa
  • Other African Union
  • Rest of Middle East & Africa

Research Sources and Bibliography

• 1. National Institutes of Health. (2025). NIH Genomic Data Science Program Report. NIH.
• 2. European Bioinformatics Institute. (2025). EMBL-EBI Annual Scientific Report. EMBL-EBI.
• 3. World Health Organization. (2025). WHO Genomics and Precision Health Report. WHO.
• 4. USA Food and Drug Administration. (2024). FDA Framework for Regulation of AI in Drug Development. FDA.
• 5. Organisation for Economic Co-operation and Development. (2025). OECD Biotechnology Statistics Report. OECD.
• 6. National Center for Biotechnology Information. (2025). NCBI Sequence Database Statistics. NCBI.

This bibliography is provided for reader reference. The full Future Market Insights report contains the complete reference list with publication dates, URLs, and supporting data for all cited works.

This Report Answers

• Estimating the size of the market and revenue projections from 2026 to 2036.
• Segmentation analysis across product, application, sector, offering.
• Regional and country level insights covering more than 30 markets.
• Competitive landscape assessment including company positioning, benchmarking, and key developments.
• Identification of growth drivers, restraints, and strategic opportunities across segments.
• Investment opportunity assessment across high growth segments and geographies.
• Supply chain and distribution channel analysis.
• Data delivery in PDF and Excel formats.